Skip to main content
. 2020 Mar 2;76(Pt 3):116–129. doi: 10.1107/S2053230X20001466

Table 5. Kinetics of omalizumab, the omalizumab-derived Fabs and scFv binding to IgE-Fc.

Molecule immobilized k on1 (M −1 s−1) k on2 (M −1 s−1) k off1 (s−1) k off2 (s−1)
Omalizumab 3.3 × 105 2.9 × 105 7.0 × 10−4 1.2 × 10−2
FabXol 5.7 × 105 4.4 × 105 5.6 × 10−4 1.2 × 10−2
FabXol2 5.1 × 105 3.3 × 105 4.5 × 10−4 1.1 × 10−2
FabXol3 9.7 × 105 2.7 × 105 3.3 × 10−4 9.0 × 10−3
scFvXol 6.9 × 105 3.1 × 105 2.9 × 10−4 8.7 × 10−3